Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

Find Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Near You

Effectiveness of A Personalized Mobile Application Providing Temperature-Related Health Risk Warnings and Protective Recommendations for Patients With Chronic Obstructive Pulmonary Disease

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will test whether a personalized mobile application that provides temperature-related health risk warnings and protective recommendations can reduce acute exacerbations in people with chronic obstructive pulmonary disease (COPD). Researchers will compare participants who receive the mobile application in addition to usual care with those who receive usual care alone. The main question is whether the mobile application reduces the number of COPD acute exacerbation events over 12 months. The study will also evaluate secondary outcomes including quality of life, functional capacity, symptoms, psychological status, physiological and biochemical indicators, environmental temperature risk perception, and participants' use of the mobile application.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 80
Healthy Volunteers: f
View:

• Tertiary hospitals;

• Hospitals with respiratory wards that admit patients with COPD;

• Hospitals with a well-established electronic health record system and follow-up capability;

• Hospitals able to assign a study coordinator.

• Age \>=40 years and \<=80 years, with no restriction on sex;

• Patients with stable chronic obstructive pulmonary disease;

• At least 1 severe acute exacerbation requiring hospitalization, or at least 2 moderate acute exacerbations requiring outpatient or emergency care, within the previous year;

• Local permanent residents with a duration of residence \>=6 months;

• Patients who voluntarily agree to participate, are expected to have good adherence, are able to sign informed consent;

• Patients who own a smartphone or other smart device.

Locations
Other Locations
China
Beijing Anzhen Hospital, Capital Medical University
RECRUITING
Beijing
Beijing Huairou Hospital
RECRUITING
Beijing
Civil Aviation General Hospital
RECRUITING
Beijing
Emergency General Hospital
RECRUITING
Beijing
Contact Information
Primary
Can Zhang, Ph.D.
zhangcan@nieh.chinacdc.cn
+8613655181384
Time Frame
Start Date: 2026-08-04
Estimated Completion Date: 2027-08
Participants
Target number of participants: 240
Treatments
Experimental: Personalized Temperature Risk Intervention + Usual COPD Care
No_intervention: Usual COPD Care
Sponsors
Leads: Tiantian Li

This content was sourced from clinicaltrials.gov